Old CIC Events

Antibody-Drug Conjugates Targeting EGFR in Ovarian Cancer
Sheila Almaraz — Centro de Investigación del Cáncer (Universidad de Salamanca - CSIC)

Structure of Centromeric Chromatin and Its Consequences for Genome Stability
Carlos Sacristán López — Hubrecht Institute, Utrech (Netherlands)

Metabolic Control of Cell Fate in Regeneration and Cancer
Almudena Chaves Pérez — Memorial Sloan Kettering Cancer Centre (NY)

defensa de tesis: Unraveling the role of RNA modifications in immune evasion and tumor progression in prostate cancer
Ana Macrina Añazco Guenkova — Programa de doctorado de biociencias: biología y clínica de cáncer

Dissecting metastatic Bladder Cancer
Jesús M Paramio — CIEMAT and Inst Inv Biomed Univ Hosp “12 de Octubre”

Defining mechanisms of genomic evolution in cancer
Sarah McClelland, PhD — Barts Cancer Institute, Queen Mary University of London

Academic model for CAR-T development: ARI0002h for multiple myeloma and beyond
Carlos Fernández de Larrea — Hospital Clínic de Barcelona

Preclinical and clinical evaluation of belantamab mafodotin based immunotherapy combinations in multiple myeloma
Mauro Lorenzo Mohamed — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC

Tuning the ribosome in health and disease
Anders H. Lund — Biotech Research and Innovation Centre University of Copenhagen

Inherited and acquired genetic biomarkers in patients with Mast Cell Activation Syndromes and Mastocytosis
Paula Navarro — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC